BRPI0822058A2 - Derivados de 5-oxo-3-pirrolidinacarboxamida como moduladores de p2x7 - Google Patents

Derivados de 5-oxo-3-pirrolidinacarboxamida como moduladores de p2x7

Info

Publication number
BRPI0822058A2
BRPI0822058A2 BRPI0822058-1A BRPI0822058A BRPI0822058A2 BR PI0822058 A2 BRPI0822058 A2 BR PI0822058A2 BR PI0822058 A BRPI0822058 A BR PI0822058A BR PI0822058 A2 BRPI0822058 A2 BR PI0822058A2
Authority
BR
Brazil
Prior art keywords
pyrrolidinecarboxamide
modulators
oxo
derivatives
pyrrolidinecarboxamide derivatives
Prior art date
Application number
BRPI0822058-1A
Other languages
English (en)
Inventor
Jon Graham Anthony Steadman
Daryl Simon Walter
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0724623A external-priority patent/GB0724623D0/en
Priority claimed from GB0800839A external-priority patent/GB0800839D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BRPI0822058A2 publication Critical patent/BRPI0822058A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
BRPI0822058-1A 2007-12-18 2008-12-17 Derivados de 5-oxo-3-pirrolidinacarboxamida como moduladores de p2x7 BRPI0822058A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0724623A GB0724623D0 (en) 2007-12-18 2007-12-18 Novel compounds
GB0800839A GB0800839D0 (en) 2008-01-17 2008-01-17 Novel compounds
PCT/EP2008/067733 WO2009077559A2 (en) 2007-12-18 2008-12-17 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators

Publications (1)

Publication Number Publication Date
BRPI0822058A2 true BRPI0822058A2 (pt) 2015-06-23

Family

ID=40795940

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0822058-1A BRPI0822058A2 (pt) 2007-12-18 2008-12-17 Derivados de 5-oxo-3-pirrolidinacarboxamida como moduladores de p2x7

Country Status (10)

Country Link
US (1) US20100292295A1 (pt)
EP (1) EP2231153A2 (pt)
JP (1) JP2011506554A (pt)
KR (1) KR20100099178A (pt)
CN (1) CN101945655A (pt)
AU (1) AU2008337506A1 (pt)
BR (1) BRPI0822058A2 (pt)
CA (1) CA2709821A1 (pt)
RU (1) RU2010129929A (pt)
WO (1) WO2009077559A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2783236C (en) 2009-12-08 2020-03-10 Vanderbilt University Improved methods and compositions for vein harvest and autografting
EP2542670A2 (en) 2010-03-05 2013-01-09 President and Fellows of Harvard College Induced dendritic cell compositions and uses thereof
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
CN103687860B (zh) 2011-07-22 2016-06-08 埃科特莱茵药品有限公司 作为p2x7受体拮抗剂的杂环酰胺衍生物
US9409917B2 (en) 2012-01-20 2016-08-09 Actelion Pharmaceuticals Ltd. Heterocyclic amide derivatives as P2X7 receptor antagonists
EP2875829A4 (en) 2012-03-09 2015-12-02 Inst Pasteur Shanghai Cas COMPONENT AND METHOD FOR THE TREATMENT OF VIRAL DISEASES
WO2014091415A1 (en) 2012-12-12 2014-06-19 Actelion Pharmaceuticals Ltd Indole carboxamide derivatives as p2x7 receptor antagonists
KR102232744B1 (ko) 2012-12-18 2021-03-26 이도르시아 파마슈티컬스 리미티드 Ｐ２ｘ７ 수용체 길항제로서의 인돌 카르복사미드 유도체
ES2616883T3 (es) 2013-01-22 2017-06-14 Actelion Pharmaceuticals Ltd. Derivados amida heterocíclicos como antagonistas del receptor P2X7
CA2896790C (en) 2013-01-22 2022-05-10 Actelion Pharmaceuticals Ltd Heterocyclic amide derivatives as p2x7 receptor antagonists
EP3773557A1 (en) * 2018-03-29 2021-02-17 Centre national de la recherche scientifique P2rx7 modulators in therapy
US20240199542A1 (en) 2021-03-22 2024-06-20 Bayer Aktiengesellschaft Substituted pyrrolidin-2-ones, salts thereof and their use as herbicidally active substances
WO2022268520A1 (de) 2021-06-21 2022-12-29 Bayer Aktiengesellschaft Verwendung von substituierten pyrrolidinonen oder deren salzen zur steigerung der stresstoleranz in pflanzen.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100298285A1 (en) * 2006-03-16 2010-11-25 Kelly Michael G Biclycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
MX2009000117A (es) * 2006-07-06 2009-01-23 Glaxo Group Ltd N-fenilmetil-5-oxo-prolin-2-amidas sustituidas como antagonistas de receptores p2x7 y sus metodos de uso.
GB0705882D0 (en) * 2007-03-27 2007-05-02 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
EP2231153A2 (en) 2010-09-29
WO2009077559A3 (en) 2009-09-24
RU2010129929A (ru) 2012-01-27
WO2009077559A2 (en) 2009-06-25
CN101945655A (zh) 2011-01-12
AU2008337506A1 (en) 2009-06-25
JP2011506554A (ja) 2011-03-03
CA2709821A1 (en) 2009-06-25
US20100292295A1 (en) 2010-11-18
KR20100099178A (ko) 2010-09-10

Similar Documents

Publication Publication Date Title
FR24C1047I2 (fr) Derive de 4-pyrimidinesulfamide
BRPI0809930A2 (pt) Derivados de carboxamida imidazolidina como moduladores de p2x7
BRPI0822058A2 (pt) Derivados de 5-oxo-3-pirrolidinacarboxamida como moduladores de p2x7
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
BRPI0810202A2 (pt) Derivados de piridina
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0817935A2 (pt) Derivados de biarila
EP2376493A4 (en) DIHYDROPYRIMIDOPYRIMIDINDERIVAT
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
EP2380877A4 (en) PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
EP2226315A4 (en) 2-aminoquinazoline DERIVATIVE
BRPI0814236A2 (pt) Derivados de quinazolinamida
DK2308877T3 (da) Imidazopyridin-2-on-derivater
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
BRPI0812518A2 (pt) Derivados de indazolamida
CU23870B1 (es) Derivados de ciclopropilamida como moduladores h3
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
BRPI0817562A2 (pt) derivados de n-hidroxilsulfonamida como novos doadores de niltroxil fisiologicamente úteis
EP2336132A4 (en) MORPHOLINPURINDERIVAT
BRPI1013844A2 (pt) derivados de piridina-isoxazol

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.